Drugmakers, insurers, hospitals, pharmacies, medical devices, clinical updates, and healthcare business leaders.
In a new promotional push tied to home-based clinical monitoring, CVS Health’s messaging centers on identifying abnormal heart rhythms earlier to reduce the risk of complications such as stroke and heart failure. The company did not provide performance metrics in the announcement.
THE APEX TIMES
THE APEX TIMES
Pfizer’s stock climbed 2.96% on the latest trading day, ending at $29.21, even as the market pulled back.
THE APEX TIMES
A recent market analysis highlights how sharply Eli Lilly’s stock has risen and raises the question of whether today’s price is fully supported by the company’s expected cash flows.
THE APEX TIMES
The company says it remains on course to reach $100 billion in recorded revenue even as its medical technology business faces short-term pressures, according to remarks reported by Yahoo Finance and CFO Dive.
THE APEX TIMES
A recent market comparison highlights Pfizer’s dividend yield near 6% versus General Mills around 7%, underscoring how investors screen different sectors for cash return.
THE APEX TIMES
A market-focused comparison highlighted Pfizer’s payout yield near 6.3% versus British American Tobacco’s around 6.0%, underscoring how investors weigh current income against business and balance-sheet risks.
THE APEX TIMES
A market write-up highlighted Pfizer’s dividend yield near 6.3% and set it against Healthpeak Properties’ roughly 6% yield as investors weigh income-focused positioning across different health-care-linked sectors.
THE APEX TIMES
Eli Lilly, Merck and AbbVie pushed higher, with Lilly climbing above its 50-day moving average to reach its strongest level since August, as investors returned to healthcare stocks.
THE APEX TIMES
A new market roundup comparing high-yield names put Pfizer’s indicated dividend yield at 6.3% versus Edison International’s 6.0%, underscoring how investors are weighing income against company-specific risk profiles.
